Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids

J Med Chem. 2020 Apr 9;63(7):3723-3736. doi: 10.1021/acs.jmedchem.0c00069. Epub 2020 Mar 19.

Abstract

Semisynthetic artemisinins and other bioactive peroxides are best known for their powerful antimalarial activities, and they also show substantial activity against schistosomes-another hemoglobin-degrading pathogen. Building on this discovery, we now describe the initial structure-activity relationship (SAR) of antischistosomal ozonide carboxylic acids OZ418 (2) and OZ165 (3). Irrespective of lipophilicity, these ozonide weak acids have relatively low aqueous solubilities and high protein binding values. Ozonides with para-substituted carboxymethoxy and N-benzylglycine substituents had high antischistosomal efficacies. It was possible to increase solubility, decrease protein binding, and maintain the high antischistosomal activity in mice infected with juvenile and adult Schistosoma mansoni by incorporating a weak base functional group in these compounds. In some cases, adding polar functional groups and heteroatoms to the spiroadamantane substructure increased the solubility and metabolic stability, but in all cases decreased the antischistosomal activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adamantane / analogs & derivatives
  • Adamantane / pharmacokinetics
  • Adamantane / therapeutic use*
  • Adamantane / toxicity
  • Animals
  • Carboxylic Acids / chemical synthesis
  • Carboxylic Acids / pharmacokinetics
  • Carboxylic Acids / therapeutic use*
  • Carboxylic Acids / toxicity
  • Cell Line, Tumor
  • Female
  • HEK293 Cells
  • Heterocyclic Compounds, 1-Ring / chemical synthesis
  • Heterocyclic Compounds, 1-Ring / pharmacokinetics
  • Heterocyclic Compounds, 1-Ring / therapeutic use*
  • Heterocyclic Compounds, 1-Ring / toxicity
  • Humans
  • Mice
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Schistosoma mansoni / drug effects
  • Schistosomiasis mansoni / drug therapy
  • Schistosomicides / chemical synthesis
  • Schistosomicides / pharmacokinetics
  • Schistosomicides / therapeutic use*
  • Schistosomicides / toxicity
  • Spiro Compounds / chemical synthesis
  • Spiro Compounds / pharmacokinetics
  • Spiro Compounds / therapeutic use*
  • Spiro Compounds / toxicity
  • Structure-Activity Relationship

Substances

  • Carboxylic Acids
  • Heterocyclic Compounds, 1-Ring
  • Schistosomicides
  • Spiro Compounds
  • Adamantane